TargetMol

[Des-Arg9]-Bradykinin acetate

Product Code:
 
TAR-TP1445
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-TP1445-5mg5mg£108.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-TP1445-10mg10mg£132.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-TP1445-25mg25mg£213.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-TP1445-50mg50mg£282.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-TP1445-100mg100mg£385.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-TP1445-200mg200mg£531.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-TP1445-500mg500mg£782.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
[Des-Arg9]-Bradykinin acetate is a selective agonist of Bradykinin B1 receptor.
CAS:
23827-91-0
Formula:
C46H65N11O12
Molecular Weight:
964.07
Pathway:
GPCR/G Protein
Purity:
0.9905
SMILES:
O=C(O)[C@@H](NC([C@@H]1CCCN1C([C@@H](NC([C@@H](NC(CNC([C@@H]2CCCN2C([C@@H]3CCCN3C([C@H](CCCNC(N)=N)N)=O)=O)=O)=O)CC4=CC=CC=C4)=O)CO)=O)=O)CC5=CC=CC=C5.CC(O)=O
Target:
Bradykinin Receptor

References

Leeb-Lundberg LM, et al. International union of pharmacology. XLV. Classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences. Pharmacol Rev. 2005 Mar;57(1):27-77.